USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Stamicarbon B.V. Acting Under THE Name OF MT Innovation Center

USPTO PatentsView assignee record - 13 granted patents across 11 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus).

RSS updates for this company

The verdict

According to USPTO PatentsView, Stamicarbon ranks #21,827 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 11 technology areas.

#21,827
of 49,997 US assignees by volume
Top 48%
by Innovation Score (35.9/100)
13.9
avg claims per patent
-82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21827 · Foreign Corporation #21,827 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,827/49,997
  • PHOTO-FINISH SRX Cardio
  • CPC-FOCUS B01J · 11 areas
  • INNOV-THIN 35.9/100
  • CLAIMS-RICH 13.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -82% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: SRX Cardio, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Stamicarbon’s 35.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Stamicarbon

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Stamicarbon's Innovation Score is 35.9/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Stamicarbon?

Each dot is one of Stamicarbon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Stamicarbon’s own 13.9 claims/patent is at or below the 14.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Stamicarbon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 510152025 Granted patents (volume) Avg claims / patent SRX Cardio, LLC - 13, 14.38SRX CardioSSG International, LLC - 13, 12.46SSG InternationalST Engineering Aerospace Ltd - 13, 17.62ST Engineering Ae…ST. Jude Medical Luxembourg Holdings II S.A.R.L. (“SJM LUX II”) - 13, 21ST Jude Medical L…Staples THE Office Superstore, LLC - 13, 6.92Staples THE Offic…Starkeys LLC - 13, 22StarkeysStatoil Gulf Services LLC - 13, 20.23Statoil Gulf Serv…Staubli Electrical Connectors AG - 13, 12.92Staubli Electrica…Stamicarbon B.V. Acting Under THE Name OF MT Innovation Center - 13, 13.92Stamicarbon B V A…
Stamicarbon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Stamicarbon's grants concentrate

Stamicarbon B.V. Acting Under THE Name OF MT Innovation Center is a focused PatentsView assignee: 11 CPC subclasses with 69.2% of grants classified under B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2020. By volume, Stamicarbon sits between SRX Cardio, LLC and Staubli Electrical Connectors AG.

Stamicarbon's three-year grant acceleration

Stamicarbon B.V. Acting Under THE Name OF MT Innovation Center shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Stamicarbon's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Stamicarbon holds 13 patents at rank #21,762, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Stamicarbon

By rank, the assignees closest to #21,762 in granted patent volume.

Leaders in B01J (Chemical OR Physical Processes)

Other assignees with the most granted patents in Stamicarbon's primary technology class.

Stamicarbon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 20162017201820202022 1
USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Stamicarbon B.V. Acting Under THE Name OF MT Innovation Center patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 3 23.1%
2017 4 30.8%
2018 4 30.8%
2020 1 7.7%
2022 1 7.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Stamicarbon B.V. Acting Under THE Name OF MT Innovation Center's patent record in context - here's where to go next.

  • Stamicarbon B.V. Acting Under THE Name OF MT Innovation Center's lead technology class is B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus), 69.2% of its portfolio - see every assignee active in that class. Explore B01J
  • Ranked #21,827 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Stamicarbon B.V. Acting Under THE Name OF MT Innovation Center against SRX Cardio, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.